TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 407,559 | 347,468 | 326,423 |
Financial expenses | 3,852 | 2,910 | 2,139 |
Earnings before taxes | 11,282 | 20,332 | 17,418 |
EBITDA | 29,842 | 35,491 | 27,492 |
Total assets | 365,505 | 331,357 | 318,603 |
Current assets | 186,582 | 143,352 | 125,250 |
Current liabilities | 129,459 | 68,547 | 53,596 |
Equity capital | 220,953 | 165,500 | 152,576 |
- share capital | 6,682 | 7,271 | 7,412 |
Employees (average) | 312 | 278 | 256 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 60.5% | 49.9% | 47.9% |
Turnover per employee | 1,306 | 1,250 | 1,275 |
Profit as a percentage of turnover | 2.8% | 5.9% | 5.3% |
Return on assets (ROA) | 4.1% | 7.0% | 6.1% |
Current ratio | 144.1% | 209.1% | 233.7% |
Return on equity (ROE) | 5.1% | 12.3% | 11.4% |
Change turnover | 88,236 | 27,224 | 68,501 |
Change turnover % | 28% | 9% | 27% |
Chg. No. of employees | 34 | 22 | 55 |
Chg. No. of employees % | 12% | 9% | 27% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.